Emergent BioSolutions Inc (NYSE:EBS)

2.15
Delayed Data
As of Nov 29
 +0.14 / +6.97%
Today’s Change
1.81
Today|||52-Week Range
16.66
-81.80%
Year-to-Date

Today’s Trading

Previous close2.01
Today’s open2.00
Day’s range2.00 - 2.36
Volume1,654,791
Average volume (3 months)2,102,808
Market cap$107.8M
Data as of 3:59pm ET, 11/29/2023

Growth & Valuation

Earnings growth (last year)-203.50%
Earnings growth (this year)+29.90%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)-37.47%
P/E ratioNM
Price/Sales0.53
Price/Book0.08

Competitors

----
--Lexagene Holdings In...0.000.00%
LPTXLeap Therapeutics In...+0.03+1.22%
----
Data as of 3:59pm ET, 11/29/2023

Financials

Next reporting dateFebruary 22, 2024
EPS forecast (this quarter)$1.67
Annual revenue (last year)$1.1B
Annual profit (last year)-$223.8M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts